X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Pfizer with Unichem Lab - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PFIZER vs UNICHEM LAB - Comparison Results

PFIZER    Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PFIZER UNICHEM LAB PFIZER/
UNICHEM LAB
 
P/E (TTM) x 31.0 29.7 104.5% View Chart
P/BV x 4.9 3.1 157.8% View Chart
Dividend Yield % 0.7 0.6 108.1%  

Financials

 PFIZER   UNICHEM LAB
EQUITY SHARE DATA
    PFIZER
Mar-16
UNICHEM LAB
Mar-16
PFIZER/
UNICHEM LAB
5-Yr Chart
Click to enlarge
High Rs2,724334 815.6%   
Low Rs1,611174 925.9%   
Sales per share (Unadj.) Rs440.9146.9 300.1%  
Earnings per share (Unadj.) Rs48.711.9 409.4%  
Cash flow per share (Unadj.) Rs75.816.2 468.1%  
Dividends per share (Unadj.) Rs15.002.00 750.0%  
Dividend yield (eoy) %0.70.8 87.9%  
Book value per share (Unadj.) Rs462.9105.1 440.4%  
Shares outstanding (eoy) m45.7590.84 50.4%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x4.91.7 284.4%   
Avg P/E ratio x44.521.4 208.4%  
P/CF ratio (eoy) x28.615.7 182.3%  
Price / Book Value ratio x4.72.4 193.8%  
Dividend payout %30.816.8 183.2%   
Avg Mkt Cap Rs m99,16323,073 429.8%   
No. of employees `0002.95.7 50.9%   
Total wages/salary Rs m2,7582,558 107.8%   
Avg. sales/employee Rs Th6,981.72,352.5 296.8%   
Avg. wages/employee Rs Th954.5450.9 211.7%   
Avg. net profit/employee Rs Th771.1190.4 404.9%   
INCOME DATA
Net Sales Rs m20,17013,346 151.1%  
Other income Rs m857192 446.8%   
Total revenues Rs m21,02813,538 155.3%   
Gross profit Rs m4,3101,639 263.0%  
Depreciation Rs m1,239390 317.6%   
Interest Rs m529 18.1%   
Profit before tax Rs m3,9231,412 277.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m0-4 0.0%   
Extraordinary Inc (Exp) Rs m99-35 -280.1%   
Tax Rs m1,794293 613.1%   
Profit after tax Rs m2,2281,080 206.2%  
Gross profit margin %21.412.3 174.0%  
Effective tax rate %45.720.7 220.7%   
Net profit margin %11.08.1 136.4%  
BALANCE SHEET DATA
Current assets Rs m16,2995,979 272.6%   
Current liabilities Rs m7,5942,432 312.2%   
Net working cap to sales %43.226.6 162.4%  
Current ratio x2.12.5 87.3%  
Inventory Days Days6563 103.5%  
Debtors Days Days2660 42.7%  
Net fixed assets Rs m8,6226,403 134.7%   
Share capital Rs m458182 251.8%   
"Free" reserves Rs m20,7229,293 223.0%   
Net worth Rs m21,1809,548 221.8%   
Long term debt Rs m25230 10.9%   
Total assets Rs m29,13712,843 226.9%  
Interest coverage x755.550.0 1,510.0%   
Debt to equity ratio x00 4.9%  
Sales to assets ratio x0.71.0 66.6%   
Return on assets %7.78.6 88.7%  
Return on equity %10.511.3 93.0%  
Return on capital %19.014.3 132.5%  
Exports to sales %0.129.2 0.2%   
Imports to sales %17.56.3 275.5%   
Exports (fob) Rs m123,900 0.3%   
Imports (cif) Rs m3,526847 416.4%   
Fx inflow Rs m524,356 1.2%   
Fx outflow Rs m1401,162 12.0%   
Net fx Rs m-883,194 -2.8%   
CASH FLOW
From Operations Rs m3,4361,119 307.1%  
From Investments Rs m-6,991-853 819.3%  
From Financial Activity Rs m-619-334 185.2%  
Net Cashflow Rs m-4,174-68 6,110.5%  

Share Holding

Indian Promoters % 0.0 50.1 -  
Foreign collaborators % 63.9 0.0 -  
Indian inst/Mut Fund % 7.5 15.1 49.7%  
FIIs % 4.9 3.0 163.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 23.7 31.7 74.8%  
Shareholders   85,207 20,176 422.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PFIZER With:   CADILA HEALTHCARE  TTK HEALTHCARE  ORCHID PHARMA LTD  DISHMAN PHARMA  J.B.CHEMICALS  

Compare PFIZER With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Weak Start to the Week; PSU & Metal Stocks Fall(Closing)

Indian share markets continued to witness selling pressure in the afternoon session as benchmark Sensex slipped below the 34,000-mark.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Here's What You Should Do in this Market Crash(The 5 Minute Wrapup)

Feb 6, 2018

The market correction has provided a golden opportunity to buy five high-quality safe stocks.

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

When Small is Not Always Beautiful(Chart Of The Day)

Feb 6, 2018

Big companies enjoying tax deductions and exemptions have an edge over the small companies.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

PFIZER SHARE PRICE


Feb 19, 2018 (Close)

TRACK PFIZER

COMPARE PFIZER WITH

MARKET STATS